Stockreport

Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026

Elutia, Inc. - Class A  (ELUT) 
PDF GAITHERSBURG, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today an [Read more]